and to facilitate access to health
and to facilitate access to health
products in Greece
important market share and is an
established player in the Greek
Pharma Industry / is ranked
amongst the major pharma
companies in Greece.
development and manufacturing
to commercialisation, Medicair has throughout the years created a portfolio of off-patent blockbuster, value-added and niche medicines, covering all major therapeutic areas.
pharmaceutical company based in Greece.
process
of turnover
in R&D
new
developments
yearly
90
40
25
240
and success locally, following the construction
of our own manufacturing facilities in 2012,
we began focusing on the distribution of our
products globally.
We have established solid strategic
partnerships with major pharma companies
for the licensing of our developments and the
distribution of our own branded medicines.
of turnover
in R&D
developments
yearly
Strict measures are in place, safeguarding that every single product coming out of our premises is of high quality, while at the same time meeting all regulations and registration policies.
reasons for
selecting
Medicair for
Production
and
Development
